相关实验视频
Updated: Jun 29, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.7K
4因子前列红素复合度对逆转XA因子抑制剂在创伤性脑内出血患者中的作用
Jessica L Rauh1, Taron Torosian1, Anothony Thompson2
1General Surgery, Wake Forest School of Medicine, Winston Salem, NC, USA.
The American surgeon
|March 28, 2024
概括
四因子前激素复合缩物 (4F-PCC) 没有改善因子Xa抑制剂治疗轻度创伤性脑损伤 (mTBI) 患者的结果. 这项研究在内出血进展或神经系统衰退方面没有发现显著差异.
科学领域:
- 创伤外科 手术 创伤外科
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- Xa因子抑制剂 (XaI) 是广泛使用的抗凝剂.
- 对XaI的逆转药物,如4因子前素复合缩物 (4F-PCC),对于管理出血事件至关重要.
- 在XAI的轻度创伤性脑损伤 (mTBI) 患者中,4F-PCC的疗效仍然不确定.
研究的目的:
- 评估在服用XaI的mTBI患者中4F-PCC的实用性.
- 为了比较结果,包括内出血 (ICH) 进展和神经衰退,在XAI接受4F-PCC和不接受的mTBI患者之间.
主要方法:
- 在6年内在1级创伤中心对XAI上出现mTBI的患者的回顾性评估.
- 对接受4F-PCC和不接受4F-PCC患者之间的结局进行比较.
- 分析包括在48小时内的神经衰退,需要神经外科干预,以及ICH进展.
主要成果:
- 包括140名患者,103名 (74%) 接受了4F-PCC,37名 (26%) 没有.
- 在入院后48小时内,在神经衰退方面没有发现显著差异.
- 在需要神经外科干预或ICH进展方面没有发现显著差异 (16%与14%,P = .77).
结论:
- 在XAI患者的mTBI后的4F-PCC管理没有影响ICH进展,神经衰退或神经外科干预的需要.
- 这些发现表明,4F-PCC可能在所有涉及XaI的mTBI病例中都不是必不可少的.
- 需要使用更大的样本大小进行进一步的研究来证实这些发现.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
7.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Clot Retraction and Fibrinolysis
5.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.8K
Coagulation
6.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.5K
Introduction to Hemostasis
7.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.6K
Formation of the Platelet Plug
6.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.1K

